{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:14:24Z","timestamp":1790889264975,"version":"4.1.0"},"reference-count":34,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2024,10,31]]},"DOI":"10.5582\/bst.2024.01096","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T22:13:27Z","timestamp":1720217607000},"page":"482-491","source":"Crossref","is-referenced-by-count":17,"title":["Ligustrazine alleviates the progression of coronary artery calcification by inhibiting caspase-3\/GSDME mediated pyroptosis"],"prefix":"10.5582","volume":"18","author":[{"given":"Honghui","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Zhengzhou University, Central China Fuwai Hospital, Zhengzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guian","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhengzhou University, Central China Fuwai Hospital, Zhengzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingman","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhengzhou University, Central China Fuwai Hospital, Zhengzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhengzhou University, Central China Fuwai Hospital, Zhengzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: From mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020; 159:4-33.","DOI":"10.1016\/j.addr.2020.07.019"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Anzaki K, Kanda D, Ikeda Y, Takumi T, Tokushige A, Ohmure K, Sonoda T, Arikawa R, Ohishi M. Impact of malnutrition on prognosis and coronary artery calcification in patients with stable coronary artery disease. Curr Probl Cardiol. 2023; 48:101185.","DOI":"10.1016\/j.cpcardiol.2022.101185"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Samadi S, Sadeghi M, Dashtbayaz RJ, Nezamdoost S, Mohammadpour AH, Jomehzadeh V. Prognostic role of osteoprotegerin and risk of coronary artery calcification: A systematic review and meta-analysis. Biomark Med. 2023; 17:171-180.","DOI":"10.2217\/bmm-2022-0621"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kelly-Arnold A, Maldonado N, Laudier D, Aikawa E, Cardoso L, Weinbaum S. Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries. Proc Natl Acad Sci U S A. 2013; 110:10741-10746.","DOI":"10.1073\/pnas.1308814110"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Narula N, Olin JW, Narula N. Pathologic disparities between peripheral artery disease and coronary artery disease. Arterioscler Thromb Vasc Biol. 2020; 40:1982-1989.","DOI":"10.1161\/ATVBAHA.119.312864"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Opdebeeck B, D&apos;Haese PC, Verhulst A. Molecular and cellular mechanisms that induce arterial calcification by indoxyl sulfate and p-cresyl sulfate. Toxins (Basel). 2020; 12:58.","DOI":"10.3390\/toxins12010058"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Demola P, Ristalli F, Hamiti B, Meucci F, Di Mario C, Mattesini A. New advances in the treatment of severe coronary artery calcifications. Cardiol Clin. 2020; 38:619-627.","DOI":"10.1016\/j.ccl.2020.07.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Henein M, Granasen G, Wiklund U, Schmermund A, Guerci A, Erbel R, Raggi P. High dose and long-term statin therapy accelerate coronary artery calcification. Int J Cardiol. 2015; 184:581-586.","DOI":"10.1016\/j.ijcard.2015.02.072"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Leopold JA. Vascular calcification: Mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med. 2015; 25:267-274.","DOI":"10.1016\/j.tcm.2014.10.021"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Demer LL, Tintut Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol. 2014; 34:715-723.","DOI":"10.1161\/ATVBAHA.113.302070"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pang Q, Wang P, Pan Y, Dong X, Zhou T, Song X, Zhang A. Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease. Cell Death Dis. 2022; 13:283.","DOI":"10.1038\/s41419-022-04735-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wen C, Yang X, Yan Z, Zhao M, Yue X, Cheng X, Zheng Z, Guan K, Dou J, Xu T, Zhang Y, Song T, Wei C, Zhong H. Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification. Int J Cardiol. 2013; 168:2242-2247.","DOI":"10.1016\/j.ijcard.2013.01.211"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wang Y, Gao W, Shi X, Ding J, Liu W, He H, Wang K, Shao F. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017; 547:99-103.","DOI":"10.1038\/nature22393"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shi J, Gao W, Shao F. Pyroptosis: Gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017; 42:245-254.","DOI":"10.1016\/j.tibs.2016.10.004"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhang Z, Zhang Y, Xia S, Kong Q, Li S, Liu X, Junqueira C, Meza-Sosa KF, Mok TMY, Ansara J, Sengupta S, Yao Y, Wu H, Lieberman J. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020; 579:415-420.","DOI":"10.1038\/s41586-020-2071-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Jiang M, Qi L, Li L, Li Y. The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov. 2020; 6:112.","DOI":"10.1038\/s41420-020-00349-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kayacan S, Sener LT, Melikoglu G, Kultur S, Albeniz I, Ozturk M. Induction of apoptosis by Centaurea nerimaniae extract in HeLa and MDA-MB-231 cells by a caspase-3 pathway. Biotech Histochem. 2018; 93:311-319.","DOI":"10.1080\/10520295.2017.1401662"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Simonet WS, Lacey DL, Dunstan CR, <i>et al.<\/i> Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 1997; 89:309-319.","DOI":"10.1016\/S0092-8674(00)80209-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun. 1997; 234:137-142.","DOI":"10.1006\/bbrc.1997.6603"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tan KB, Harrop J, Reddy M, Young P, Terrett J, Emery J, Moore G, Truneh A. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene. 1997; 204:35-46.","DOI":"10.1016\/S0378-1119(97)00509-X"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Price PA, June HH, Buckley JR, Williamson MK. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol. 2001; 21:1610-1616.","DOI":"10.1161\/hq1001.097102"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998; 12:1260-1268.","DOI":"10.1101\/gad.12.9.1260"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Min H, Morony S, Sarosi I, Dunstan CR, Capparelli C, Scully S, Van G, Kaufman S, Kostenuik PJ, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med. 2000; 192:463-474.","DOI":"10.1084\/jem.192.4.463"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Orita Y, Yamamoto H, Kohno N, Sugihara M, Honda H, Kawamata S, Mito S, Soe NN, Yoshizumi M. Role of osteoprotegerin in arterial calcification: Development of new animal model. Arterioscler Thromb Vasc Biol. 2007; 27:2058-2064.","DOI":"10.1161\/ATVBAHA.107.147868"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lin J, Wang Q, Zhou S, Xu S, Yao K. Tetramethylpyrazine: A review of its mechanisms and functions. Biomed Pharmacother. 2022; 150:113005.","DOI":"10.1016\/j.biopha.2022.113005"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Lu C, Jiang Y, Zhang F, Shao J, Wu L, Wu X, Lian N, Chen L, Jin H, Chen Q, Lu Y, Zheng S. Tetramethylpyrazine prevents ethanol-induced hepatocyte injury <i>via<\/i> activation of nuclear factor erythroid 2-related factor 2. Life Sci. 2015; 141:119-127.","DOI":"10.1016\/j.lfs.2015.08.018"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Jiang F, Qian J, Chen S, Zhang W, Liu C. Ligustrazine improves atherosclerosis in rat <i>via<\/i> attenuation of oxidative stress. Pharm Biol. 2011; 49:856-863.","DOI":"10.3109\/13880209.2010.551776"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Jiang R, Xu J, Zhang Y, Zhu X, Liu J, Tan Y. Ligustrazine alleviates acute lung injury through suppressing pyroptosis and apoptosis of alveolar macrophages. Front Pharmacol. 2021; 12:680512.","DOI":"10.3389\/fphar.2021.680512"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Zhang F, Jin H, Wu L, Shao J, Wu X, Lu Y, Zheng S. Ligustrazine disrupts lipopolysaccharide-activated NLRP3 inflammasome pathway associated with inhibition of Toll-like receptor 4 in hepatocytes. Biomed Pharmacother. 2016; 78:204-209.","DOI":"10.1016\/j.biopha.2016.01.018"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: Mechanisms and diseases. Signal Transduct Target Ther. 2021; 6:128.","DOI":"10.1038\/s41392-021-00507-5"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Wang YY, Liu XL, Zhao R. Induction of pyroptosis and its implications in cancer management. Front Oncol. 2019; 9:971.","DOI":"10.3389\/fonc.2019.00971"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ma WQ, Sun XJ, Wang Y, Zhu Y, Han XQ, Liu NF. Restoring mitochondrial biogenesis with metformin attenuates beta-GP-induced phenotypic transformation of VSMCs into an osteogenic phenotype <i>via<\/i> inhibition of PDK4\/oxidative stress-mediated apoptosis. Mol Cell Endocrinol. 2019; 479:39-53.","DOI":"10.1016\/j.mce.2018.08.012"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Osako MK, Nakagami H, Shimamura M, Koriyama H, Nakagami F, Shimizu H, Miyake T, Yoshizumi M, Rakugi H, Morishita R. Cross-talk of receptor activator of nuclear factor-kappaB ligand signaling with renin-angiotensin system in vascular calcification. Arterioscler Thromb Vasc Biol 2013; 33:1287-1296.","DOI":"10.1161\/ATVBAHA.112.301099"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Vernon M, Wilski NA, Kotas D, Cai W, Pomante D, Tiago M, Alnemri ES, Aplin AE. Raptinal induces gasdermin e-dependent pyroptosis in naive and therapy-resistant melanoma. Mol Cancer Res. 2022; 20:1811-1821.","DOI":"10.1158\/1541-7786.MCR-22-0040"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/18\/5\/18_2024.01096\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T04:15:58Z","timestamp":1731730558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/18\/5\/18_2024.01096\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2024.01096","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"article-number":"2024.01096"}}